Suscribirse

A well-fixed femoral stem facing a failed acetabular component: To exchange or not? A 5- to 15-year follow-up study - 13/01/12

Doi : 10.1016/j.otsr.2011.08.014 
E. de Thomasson , C. Conso, C. Mazel
Montsouris Mutual Hospital Institute, 42, boulevard Jourdan, 75014 Paris, France 

Corresponding author. Tel.: +33 1 56 61 64 03; fax: +33 1 56 61 64 38.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Friday 13 January 2012
This article has been published in an issue click here to access

Summary

Introduction

There is no consensus about the necessity of exchanging a stable femoral component during revision total hip arthroplasty (RTHA) when only the acetabular component requires replacement. Sparing the femoral component reduces morbidity, but can make acetabular replacement technically more difficult. Moreover, the outcome of the retained femoral component is also a question, especially with older implants.

Hypothesis

Isolated acetabular component RTHA results in lower surgical morbidity, and does not increase the risk of later femoral complications.

Patients and methods

Eighty-nine patients, mean age 68, underwent surgery (anterior approach on traction table) for isolated acetabular component revision between 1994 and 2005. The femoral component had been implanted a mean 10.5 years before revision.

Results

Fifteen patients died, mean age 84.5. Eleven patients, mean age 81.3, were lost to follow-up and four underwent revision due to a subsequent infection (range 14 months – 11 years). Fifty-nine patients were evaluated after a mean 8.6 years (range 4 – 15 years). At follow-up the mean Harris score was 89.2 [IC=6.89; 44 – 100] and the mean Merle d’Aubigné score was 15.3 [IC=1.57; 11 – 18]. Five patients (5.6%) underwent surgery again due to postoperative dislocation. Six patients underwent surgery for recurrent acetabular loosening due to allograft resorption. The size of the bone defects did not increase the risk of these failures (P>0.6). Fractures occurred in two femoral components 6 and 9 years after revision. Polyethylene wear occurred in three patients requiring two repeat revisions at 6 and 7 years. In both cases the femoral component included a titanium head, which caused the wear. Implant survival at 8.6 years was 85.16±0.117% all causes of revision combined, 88.47±0.113% if infectious causes were excluded and 93.6±0.07% if only cases of acetabular component failure were taken into account.

Conclusion

Intermediate term outcomes are satisfactory if stable femoral components are retained. Nevertheless, this procedure should be performed in situations of correctly oriented modular components. In single piece (monoblock) femoral implants, or in implants with a history of failure, this technique should be restricted to elderly and/or fragile patients.

Level of evidence

Level IV, Retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Acetabular, Revision, Arthroplasty, Morbidity, Hip


Esquema


© 2012  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.